<DOC>
	<DOC>NCT02516709</DOC>
	<brief_summary>Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.</brief_summary>
	<brief_title>Linear Source Registry for Prostate Cancer</brief_title>
	<detailed_description>This registry is being conducted to provide long term analysis on the use of the linear Civastring source for prostate cancer. Prospective data collection will record and demonstrate biochemical response rates. Long term side effects and adverse events will be monitored.</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Age &gt; 18 years old Plans to remain in care of enrolling physician for 5 years &gt; 5 years life expectancy Signed informed consent Enrolled within 6 weeks of implant or within 365 days of prior implant Not willing or able to comply with protocol visit schedule</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>